AI English summary of an SEC filing — figures as filed
Ameren said it entered into forward sale agreements on May 12, 2025 with Goldman Sachs & Co. LLC, JPMorgan Chase Bank, National Association, Barclays Bank PLC and Wells Fargo Bank, National Association, covering 5,550,416 shares (Base Shares).
Key points
AI summaryAmeren said it entered into forward sale agreements on May 12, 2025 with Goldman Sachs & Co. LLC, JPMorgan Chase Bank, National Association, Barclays Bank PLC and Wells Fargo Bank, National Association, covering 5,550,416 shares (Base Shares).
The company said it granted the Underwriters an option to buy up to 832,562 additional shares (Option Shares) within 30 days, and that the Underwriters exercised the option in full on May 13, 2025, after which it entered into additional forward sale agreements.
The company said the initial forward sale price is $91.885 per share and that it will set the settlement date, to be on or before January 15, 2027, at its discretion. Settlement is physical by default, but the company may elect cash settlement or net share settlement under certain conditions.
Ameren said the Forward Sellers sold the shares to the Underwriters on May 14, 2025, and the offering closed. It said each Forward Purchaser has the right to require physical settlement on certain events, including if it is unable to borrow shares and if Ameren declares certain dividends, and it is not limited to those events.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Ameren enters forward sale agreements for 5,550,416 shares
Ameren said it entered into forward sale agreements on May 12, 2025 with Goldman Sachs & Co. LLC, JPMorgan Chase Bank, National Association, Barclays Bank PLC and Wells Fargo Bank, National Association, covering 5,550,416 shares (Base Shares).
Source · Based on the filing body and exhibits
Underwriters exercise full option on 832,562 option shares
The company said it granted the Underwriters an option to buy up to 832,562 additional shares (Option Shares) within 30 days, and that the Underwriters exercised the option in full on May 13, 2025, after which it entered into additional forward sale agreements.
Source · Based on the filing body and exhibits
Initial forward sale price of $91.885 and settlement terms
The company said the initial forward sale price is $91.885 per share and that it will set the settlement date, to be on or before January 15, 2027, at its discretion. Settlement is physical by default, but the company may elect cash settlement or net share settlement under certain conditions.
Source · Based on the filing body and exhibits
May 14, 2025 offering closing and accelerated settlement terms
Ameren said the Forward Sellers sold the shares to the Underwriters on May 14, 2025, and the offering closed. It said each Forward Purchaser has the right to require physical settlement on certain events, including if it is unable to borrow shares and if Ameren declares certain dividends, and it is not limited to those events.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…